Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Gillespie, ME, 2013-03-15

Class:IdInstanceEdit:3219410
_displayNameGillespie, ME, 2013-03-15
_timestamp2013-03-15 18:47:04
author[Person:73681] Gillespie, Marc E
dateTime2013-03-15 22:47:03
(edited)[CandidateSet:3656389] MAPK3,(MAPK1) [cytosol] [Homo sapiens]
(modified)[CatalystActivity:76353] monooxygenase activity of Cytochrome P450 (CYP2E1 based) [endoplasmic reticulum membrane]
[CatalystActivity:76454] monooxygenase activity of Cytochrome P450 (CYP2D6 based) [endoplasmic reticulum membrane]
[CatalystActivity:192095] oxysterol 7-alpha-hydroxylase activity of Cytochrome P450 (CYP7B1 based) [endoplasmic reticulum membrane]
[CatalystActivity:211888] monooxygenase activity of Cytochrome P450 (CYP2C8 based) [endoplasmic reticulum membrane]
[CatalystActivity:212002] oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen of Cytochrome P450 (CYP2D6 based) [endoplasmic reticulum membrane]
[CatalystActivity:215605] retinoic acid 4-hydroxylase activity of Cytochrome P450 (CYP26A1 based) [endoplasmic reticulum membrane]
[PathwayDiagram:500339] Diagram of Phase I - Functionalization of compounds, Defective CYP11A1 causes AICSR, Defective CYP11B1 causes AH4, Defective CYP11B2 causes CMO-1 deficiency, Defective CYP19A1 causes AEXS, Defective CYP1B1 causes Glaucoma, Defective CYP21A2 causes AH3, Defective CYP24A1 causes HCAI, Defective CYP26B1 causes RHFCA, Defective CYP26C1 causes FFDD4, Defective CYP2U1 causes SPG56, Defective CYP4F22 causes ARCI5, Defective CYP7B1 causes SPG5A and CBAS3, Defective FMO3 causes TMAU, Defective MAOA causes BRUNS, and Defective TBXAS1 causes GHDD
[CandidateSet:2901788] Cytochrome P450 (CYP26A1 based) [endoplasmic reticulum membrane] [Homo sapiens]
[CandidateSet:2975806] Cytochrome P450 (CYP7B1 based) [endoplasmic reticulum membrane] [Homo sapiens]
[CandidateSet:2990860] Cytochrome P450 (CYP2E1 based) [endoplasmic reticulum membrane] [Homo sapiens]
List all 11 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Gillespie, ME, 2013-03-15 (3219410)
Follow Reactome